nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Gadoxetate—ABCC2—epilepsy syndrome	0.0046	1	CrCbGaD
Gadoversetamide—Arthralgia—Pregabalin—epilepsy syndrome	0.0002	0.000201	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Dizziness—Zonisamide—epilepsy syndrome	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Headache—Diazepam—epilepsy syndrome	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Anxiety—Pregabalin—epilepsy syndrome	0.000199	0.0002	CcSEcCtD
Gadoversetamide—Diarrhoea—Clonazepam—epilepsy syndrome	0.000199	0.0002	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000198	0.000199	CcSEcCtD
Gadoversetamide—Hypotension—Valproic Acid—epilepsy syndrome	0.000198	0.000199	CcSEcCtD
Gadoversetamide—Asthenia—Carbamazepine—epilepsy syndrome	0.000198	0.000199	CcSEcCtD
Gadoversetamide—Agitation—Gabapentin—epilepsy syndrome	0.000198	0.000199	CcSEcCtD
Gadoversetamide—Diarrhoea—Phenytoin—epilepsy syndrome	0.000198	0.000199	CcSEcCtD
Gadoversetamide—Discomfort—Pregabalin—epilepsy syndrome	0.000197	0.000198	CcSEcCtD
Gadoversetamide—Nausea—Fosphenytoin—epilepsy syndrome	0.000197	0.000198	CcSEcCtD
Gadoversetamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000197	0.000198	CcSEcCtD
Gadoversetamide—Erythema multiforme—Topiramate—epilepsy syndrome	0.000197	0.000197	CcSEcCtD
Gadoversetamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000196	0.000197	CcSEcCtD
Gadoversetamide—Vomiting—Felbamate—epilepsy syndrome	0.000196	0.000197	CcSEcCtD
Gadoversetamide—Dry mouth—Pregabalin—epilepsy syndrome	0.000195	0.000196	CcSEcCtD
Gadoversetamide—Pruritus—Carbamazepine—epilepsy syndrome	0.000195	0.000196	CcSEcCtD
Gadoversetamide—Rash—Felbamate—epilepsy syndrome	0.000194	0.000195	CcSEcCtD
Gadoversetamide—Eye disorder—Topiramate—epilepsy syndrome	0.000194	0.000195	CcSEcCtD
Gadoversetamide—Dermatitis—Felbamate—epilepsy syndrome	0.000194	0.000195	CcSEcCtD
Gadoversetamide—Malaise—Gabapentin—epilepsy syndrome	0.000194	0.000195	CcSEcCtD
Gadoversetamide—Tinnitus—Topiramate—epilepsy syndrome	0.000194	0.000195	CcSEcCtD
Gadoversetamide—Vertigo—Gabapentin—epilepsy syndrome	0.000193	0.000194	CcSEcCtD
Gadoversetamide—Headache—Felbamate—epilepsy syndrome	0.000193	0.000194	CcSEcCtD
Gadoversetamide—Confusional state—Pregabalin—epilepsy syndrome	0.000193	0.000194	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000193	0.000194	CcSEcCtD
Gadoversetamide—Cardiac disorder—Topiramate—epilepsy syndrome	0.000193	0.000194	CcSEcCtD
Gadoversetamide—Flushing—Topiramate—epilepsy syndrome	0.000193	0.000194	CcSEcCtD
Gadoversetamide—Syncope—Gabapentin—epilepsy syndrome	0.000193	0.000194	CcSEcCtD
Gadoversetamide—Dizziness—Clonazepam—epilepsy syndrome	0.000192	0.000193	CcSEcCtD
Gadoversetamide—Nausea—Vigabatrin—epilepsy syndrome	0.000192	0.000193	CcSEcCtD
Gadoversetamide—Vomiting—Zonisamide—epilepsy syndrome	0.000192	0.000193	CcSEcCtD
Gadoversetamide—Insomnia—Valproic Acid—epilepsy syndrome	0.000192	0.000192	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000191	0.000192	CcSEcCtD
Gadoversetamide—Oedema—Pregabalin—epilepsy syndrome	0.000191	0.000192	CcSEcCtD
Gadoversetamide—Asthenia—Lamotrigine—epilepsy syndrome	0.000191	0.000192	CcSEcCtD
Gadoversetamide—Dizziness—Phenytoin—epilepsy syndrome	0.000191	0.000192	CcSEcCtD
Gadoversetamide—Rash—Zonisamide—epilepsy syndrome	0.00019	0.000191	CcSEcCtD
Gadoversetamide—Paraesthesia—Valproic Acid—epilepsy syndrome	0.00019	0.000191	CcSEcCtD
Gadoversetamide—Palpitations—Gabapentin—epilepsy syndrome	0.00019	0.000191	CcSEcCtD
Gadoversetamide—Dermatitis—Zonisamide—epilepsy syndrome	0.00019	0.000191	CcSEcCtD
Gadoversetamide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00019	0.000191	CcSEcCtD
Gadoversetamide—Nausea—Diazepam—epilepsy syndrome	0.000189	0.00019	CcSEcCtD
Gadoversetamide—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000189	0.00019	CcSEcCtD
Gadoversetamide—Headache—Zonisamide—epilepsy syndrome	0.000189	0.00019	CcSEcCtD
Gadoversetamide—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000189	0.00019	CcSEcCtD
Gadoversetamide—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000189	0.00019	CcSEcCtD
Gadoversetamide—Angiopathy—Topiramate—epilepsy syndrome	0.000189	0.000189	CcSEcCtD
Gadoversetamide—Pruritus—Lamotrigine—epilepsy syndrome	0.000189	0.000189	CcSEcCtD
Gadoversetamide—Shock—Pregabalin—epilepsy syndrome	0.000188	0.000189	CcSEcCtD
Gadoversetamide—Somnolence—Valproic Acid—epilepsy syndrome	0.000188	0.000189	CcSEcCtD
Gadoversetamide—Immune system disorder—Topiramate—epilepsy syndrome	0.000188	0.000189	CcSEcCtD
Gadoversetamide—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000188	0.000189	CcSEcCtD
Gadoversetamide—Cough—Gabapentin—epilepsy syndrome	0.000188	0.000189	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000187	0.000188	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000187	0.000188	CcSEcCtD
Gadoversetamide—Tachycardia—Pregabalin—epilepsy syndrome	0.000187	0.000188	CcSEcCtD
Gadoversetamide—Chills—Topiramate—epilepsy syndrome	0.000187	0.000187	CcSEcCtD
Gadoversetamide—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000186	0.000187	CcSEcCtD
Gadoversetamide—Convulsion—Gabapentin—epilepsy syndrome	0.000186	0.000187	CcSEcCtD
Gadoversetamide—Skin disorder—Pregabalin—epilepsy syndrome	0.000186	0.000187	CcSEcCtD
Gadoversetamide—Hypertension—Gabapentin—epilepsy syndrome	0.000186	0.000187	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000185	0.000186	CcSEcCtD
Gadoversetamide—Vomiting—Clonazepam—epilepsy syndrome	0.000185	0.000186	CcSEcCtD
Gadoversetamide—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000184	0.000185	CcSEcCtD
Gadoversetamide—Vomiting—Phenytoin—epilepsy syndrome	0.000184	0.000185	CcSEcCtD
Gadoversetamide—Rash—Clonazepam—epilepsy syndrome	0.000183	0.000184	CcSEcCtD
Gadoversetamide—Dermatitis—Clonazepam—epilepsy syndrome	0.000183	0.000184	CcSEcCtD
Gadoversetamide—Myalgia—Gabapentin—epilepsy syndrome	0.000183	0.000184	CcSEcCtD
Gadoversetamide—Chest pain—Gabapentin—epilepsy syndrome	0.000183	0.000184	CcSEcCtD
Gadoversetamide—Arthralgia—Gabapentin—epilepsy syndrome	0.000183	0.000184	CcSEcCtD
Gadoversetamide—Nausea—Felbamate—epilepsy syndrome	0.000183	0.000184	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000183	0.000184	CcSEcCtD
Gadoversetamide—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000183	0.000184	CcSEcCtD
Gadoversetamide—Fatigue—Valproic Acid—epilepsy syndrome	0.000183	0.000183	CcSEcCtD
Gadoversetamide—Anxiety—Gabapentin—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Anorexia—Pregabalin—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Dizziness—Carbamazepine—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Headache—Clonazepam—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Rash—Phenytoin—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Mental disorder—Topiramate—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Dermatitis—Phenytoin—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000182	0.000183	CcSEcCtD
Gadoversetamide—Rash—Oxcarbazepine—epilepsy syndrome	0.000181	0.000182	CcSEcCtD
Gadoversetamide—Pain—Valproic Acid—epilepsy syndrome	0.000181	0.000182	CcSEcCtD
Gadoversetamide—Constipation—Valproic Acid—epilepsy syndrome	0.000181	0.000182	CcSEcCtD
Gadoversetamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000181	0.000182	CcSEcCtD
Gadoversetamide—Headache—Phenytoin—epilepsy syndrome	0.000181	0.000182	CcSEcCtD
Gadoversetamide—Erythema—Topiramate—epilepsy syndrome	0.000181	0.000182	CcSEcCtD
Gadoversetamide—Malnutrition—Topiramate—epilepsy syndrome	0.000181	0.000182	CcSEcCtD
Gadoversetamide—Discomfort—Gabapentin—epilepsy syndrome	0.000181	0.000182	CcSEcCtD
Gadoversetamide—Headache—Oxcarbazepine—epilepsy syndrome	0.00018	0.000181	CcSEcCtD
Gadoversetamide—Nausea—Zonisamide—epilepsy syndrome	0.000179	0.00018	CcSEcCtD
Gadoversetamide—Dry mouth—Gabapentin—epilepsy syndrome	0.000179	0.00018	CcSEcCtD
Gadoversetamide—Hypotension—Pregabalin—epilepsy syndrome	0.000179	0.00018	CcSEcCtD
Gadoversetamide—Flatulence—Topiramate—epilepsy syndrome	0.000178	0.000179	CcSEcCtD
Gadoversetamide—Tension—Topiramate—epilepsy syndrome	0.000178	0.000178	CcSEcCtD
Gadoversetamide—Dysgeusia—Topiramate—epilepsy syndrome	0.000177	0.000178	CcSEcCtD
Gadoversetamide—Confusional state—Gabapentin—epilepsy syndrome	0.000177	0.000178	CcSEcCtD
Gadoversetamide—Dizziness—Lamotrigine—epilepsy syndrome	0.000176	0.000177	CcSEcCtD
Gadoversetamide—Nervousness—Topiramate—epilepsy syndrome	0.000176	0.000177	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000176	0.000176	CcSEcCtD
Gadoversetamide—Oedema—Gabapentin—epilepsy syndrome	0.000176	0.000176	CcSEcCtD
Gadoversetamide—Vomiting—Carbamazepine—epilepsy syndrome	0.000175	0.000176	CcSEcCtD
Gadoversetamide—Back pain—Topiramate—epilepsy syndrome	0.000175	0.000176	CcSEcCtD
Gadoversetamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000174	0.000175	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000174	0.000175	CcSEcCtD
Gadoversetamide—Muscle spasms—Topiramate—epilepsy syndrome	0.000174	0.000175	CcSEcCtD
Gadoversetamide—Rash—Carbamazepine—epilepsy syndrome	0.000174	0.000175	CcSEcCtD
Gadoversetamide—Dermatitis—Carbamazepine—epilepsy syndrome	0.000174	0.000174	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000173	0.000174	CcSEcCtD
Gadoversetamide—Insomnia—Pregabalin—epilepsy syndrome	0.000173	0.000174	CcSEcCtD
Gadoversetamide—Nausea—Clonazepam—epilepsy syndrome	0.000173	0.000174	CcSEcCtD
Gadoversetamide—Headache—Carbamazepine—epilepsy syndrome	0.000173	0.000174	CcSEcCtD
Gadoversetamide—Shock—Gabapentin—epilepsy syndrome	0.000173	0.000174	CcSEcCtD
Gadoversetamide—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000172	0.000173	CcSEcCtD
Gadoversetamide—Paraesthesia—Pregabalin—epilepsy syndrome	0.000172	0.000173	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000172	0.000173	CcSEcCtD
Gadoversetamide—Nausea—Phenytoin—epilepsy syndrome	0.000172	0.000172	CcSEcCtD
Gadoversetamide—Tachycardia—Gabapentin—epilepsy syndrome	0.000171	0.000172	CcSEcCtD
Gadoversetamide—Dyspnoea—Pregabalin—epilepsy syndrome	0.000171	0.000171	CcSEcCtD
Gadoversetamide—Nausea—Oxcarbazepine—epilepsy syndrome	0.000171	0.000171	CcSEcCtD
Gadoversetamide—Vision blurred—Topiramate—epilepsy syndrome	0.000171	0.000171	CcSEcCtD
Gadoversetamide—Skin disorder—Gabapentin—epilepsy syndrome	0.000171	0.000171	CcSEcCtD
Gadoversetamide—Somnolence—Pregabalin—epilepsy syndrome	0.00017	0.000171	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.00017	0.00017	CcSEcCtD
Gadoversetamide—Tremor—Topiramate—epilepsy syndrome	0.00017	0.00017	CcSEcCtD
Gadoversetamide—Vomiting—Lamotrigine—epilepsy syndrome	0.000169	0.00017	CcSEcCtD
Gadoversetamide—Urticaria—Valproic Acid—epilepsy syndrome	0.000168	0.000169	CcSEcCtD
Gadoversetamide—Rash—Lamotrigine—epilepsy syndrome	0.000168	0.000169	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000168	0.000169	CcSEcCtD
Gadoversetamide—Dermatitis—Lamotrigine—epilepsy syndrome	0.000168	0.000169	CcSEcCtD
Gadoversetamide—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000167	0.000168	CcSEcCtD
Gadoversetamide—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000167	0.000168	CcSEcCtD
Gadoversetamide—Anorexia—Gabapentin—epilepsy syndrome	0.000167	0.000168	CcSEcCtD
Gadoversetamide—Headache—Lamotrigine—epilepsy syndrome	0.000167	0.000168	CcSEcCtD
Gadoversetamide—Decreased appetite—Pregabalin—epilepsy syndrome	0.000166	0.000167	CcSEcCtD
Gadoversetamide—Agitation—Topiramate—epilepsy syndrome	0.000166	0.000167	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000165	0.000166	CcSEcCtD
Gadoversetamide—Fatigue—Pregabalin—epilepsy syndrome	0.000165	0.000166	CcSEcCtD
Gadoversetamide—Hypotension—Gabapentin—epilepsy syndrome	0.000164	0.000165	CcSEcCtD
Gadoversetamide—Nausea—Carbamazepine—epilepsy syndrome	0.000164	0.000165	CcSEcCtD
Gadoversetamide—Pain—Pregabalin—epilepsy syndrome	0.000164	0.000164	CcSEcCtD
Gadoversetamide—Constipation—Pregabalin—epilepsy syndrome	0.000164	0.000164	CcSEcCtD
Gadoversetamide—Malaise—Topiramate—epilepsy syndrome	0.000163	0.000164	CcSEcCtD
Gadoversetamide—Vertigo—Topiramate—epilepsy syndrome	0.000163	0.000163	CcSEcCtD
Gadoversetamide—Syncope—Topiramate—epilepsy syndrome	0.000162	0.000163	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.00016	0.000161	CcSEcCtD
Gadoversetamide—Palpitations—Topiramate—epilepsy syndrome	0.00016	0.000161	CcSEcCtD
Gadoversetamide—Loss of consciousness—Topiramate—epilepsy syndrome	0.000159	0.00016	CcSEcCtD
Gadoversetamide—Insomnia—Gabapentin—epilepsy syndrome	0.000159	0.00016	CcSEcCtD
Gadoversetamide—Nausea—Lamotrigine—epilepsy syndrome	0.000158	0.000159	CcSEcCtD
Gadoversetamide—Cough—Topiramate—epilepsy syndrome	0.000158	0.000159	CcSEcCtD
Gadoversetamide—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000158	0.000158	CcSEcCtD
Gadoversetamide—Paraesthesia—Gabapentin—epilepsy syndrome	0.000158	0.000158	CcSEcCtD
Gadoversetamide—Convulsion—Topiramate—epilepsy syndrome	0.000157	0.000158	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000157	0.000157	CcSEcCtD
Gadoversetamide—Dyspnoea—Gabapentin—epilepsy syndrome	0.000157	0.000157	CcSEcCtD
Gadoversetamide—Hypertension—Topiramate—epilepsy syndrome	0.000156	0.000157	CcSEcCtD
Gadoversetamide—Somnolence—Gabapentin—epilepsy syndrome	0.000156	0.000157	CcSEcCtD
Gadoversetamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000156	0.000157	CcSEcCtD
Gadoversetamide—Dyspepsia—Gabapentin—epilepsy syndrome	0.000155	0.000155	CcSEcCtD
Gadoversetamide—Chest pain—Topiramate—epilepsy syndrome	0.000154	0.000155	CcSEcCtD
Gadoversetamide—Myalgia—Topiramate—epilepsy syndrome	0.000154	0.000155	CcSEcCtD
Gadoversetamide—Arthralgia—Topiramate—epilepsy syndrome	0.000154	0.000155	CcSEcCtD
Gadoversetamide—Anxiety—Topiramate—epilepsy syndrome	0.000154	0.000154	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000153	0.000154	CcSEcCtD
Gadoversetamide—Decreased appetite—Gabapentin—epilepsy syndrome	0.000153	0.000153	CcSEcCtD
Gadoversetamide—Discomfort—Topiramate—epilepsy syndrome	0.000152	0.000153	CcSEcCtD
Gadoversetamide—Urticaria—Pregabalin—epilepsy syndrome	0.000152	0.000153	CcSEcCtD
Gadoversetamide—Asthenia—Valproic Acid—epilepsy syndrome	0.000152	0.000153	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000152	0.000152	CcSEcCtD
Gadoversetamide—Fatigue—Gabapentin—epilepsy syndrome	0.000151	0.000152	CcSEcCtD
Gadoversetamide—Abdominal pain—Pregabalin—epilepsy syndrome	0.000151	0.000152	CcSEcCtD
Gadoversetamide—Body temperature increased—Pregabalin—epilepsy syndrome	0.000151	0.000152	CcSEcCtD
Gadoversetamide—Dry mouth—Topiramate—epilepsy syndrome	0.000151	0.000151	CcSEcCtD
Gadoversetamide—Pain—Gabapentin—epilepsy syndrome	0.00015	0.000151	CcSEcCtD
Gadoversetamide—Constipation—Gabapentin—epilepsy syndrome	0.00015	0.000151	CcSEcCtD
Gadoversetamide—Pruritus—Valproic Acid—epilepsy syndrome	0.00015	0.000151	CcSEcCtD
Gadoversetamide—Confusional state—Topiramate—epilepsy syndrome	0.000149	0.00015	CcSEcCtD
Gadoversetamide—Oedema—Topiramate—epilepsy syndrome	0.000148	0.000148	CcSEcCtD
Gadoversetamide—Shock—Topiramate—epilepsy syndrome	0.000145	0.000146	CcSEcCtD
Gadoversetamide—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000145	0.000146	CcSEcCtD
Gadoversetamide—Nervous system disorder—Topiramate—epilepsy syndrome	0.000145	0.000146	CcSEcCtD
Gadoversetamide—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000145	0.000145	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000145	0.000145	CcSEcCtD
Gadoversetamide—Tachycardia—Topiramate—epilepsy syndrome	0.000144	0.000145	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000144	0.000144	CcSEcCtD
Gadoversetamide—Skin disorder—Topiramate—epilepsy syndrome	0.000143	0.000144	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000143	0.000143	CcSEcCtD
Gadoversetamide—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000141	0.000142	CcSEcCtD
Gadoversetamide—Anorexia—Topiramate—epilepsy syndrome	0.000141	0.000141	CcSEcCtD
Gadoversetamide—Dizziness—Valproic Acid—epilepsy syndrome	0.00014	0.000141	CcSEcCtD
Gadoversetamide—Urticaria—Gabapentin—epilepsy syndrome	0.000139	0.00014	CcSEcCtD
Gadoversetamide—Abdominal pain—Gabapentin—epilepsy syndrome	0.000139	0.000139	CcSEcCtD
Gadoversetamide—Body temperature increased—Gabapentin—epilepsy syndrome	0.000139	0.000139	CcSEcCtD
Gadoversetamide—Hypotension—Topiramate—epilepsy syndrome	0.000138	0.000139	CcSEcCtD
Gadoversetamide—Asthenia—Pregabalin—epilepsy syndrome	0.000137	0.000138	CcSEcCtD
Gadoversetamide—Pruritus—Pregabalin—epilepsy syndrome	0.000135	0.000136	CcSEcCtD
Gadoversetamide—Vomiting—Valproic Acid—epilepsy syndrome	0.000135	0.000135	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000135	0.000135	CcSEcCtD
Gadoversetamide—Insomnia—Topiramate—epilepsy syndrome	0.000134	0.000134	CcSEcCtD
Gadoversetamide—Rash—Valproic Acid—epilepsy syndrome	0.000134	0.000134	CcSEcCtD
Gadoversetamide—Dermatitis—Valproic Acid—epilepsy syndrome	0.000133	0.000134	CcSEcCtD
Gadoversetamide—Headache—Valproic Acid—epilepsy syndrome	0.000133	0.000133	CcSEcCtD
Gadoversetamide—Paraesthesia—Topiramate—epilepsy syndrome	0.000133	0.000133	CcSEcCtD
Gadoversetamide—Dyspnoea—Topiramate—epilepsy syndrome	0.000132	0.000132	CcSEcCtD
Gadoversetamide—Somnolence—Topiramate—epilepsy syndrome	0.000131	0.000132	CcSEcCtD
Gadoversetamide—Diarrhoea—Pregabalin—epilepsy syndrome	0.000131	0.000132	CcSEcCtD
Gadoversetamide—Dyspepsia—Topiramate—epilepsy syndrome	0.00013	0.000131	CcSEcCtD
Gadoversetamide—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000129	0.00013	CcSEcCtD
Gadoversetamide—Decreased appetite—Topiramate—epilepsy syndrome	0.000128	0.000129	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000128	0.000128	CcSEcCtD
Gadoversetamide—Fatigue—Topiramate—epilepsy syndrome	0.000127	0.000128	CcSEcCtD
Gadoversetamide—Dizziness—Pregabalin—epilepsy syndrome	0.000127	0.000127	CcSEcCtD
Gadoversetamide—Pain—Topiramate—epilepsy syndrome	0.000126	0.000127	CcSEcCtD
Gadoversetamide—Constipation—Topiramate—epilepsy syndrome	0.000126	0.000127	CcSEcCtD
Gadoversetamide—Asthenia—Gabapentin—epilepsy syndrome	0.000126	0.000127	CcSEcCtD
Gadoversetamide—Nausea—Valproic Acid—epilepsy syndrome	0.000126	0.000126	CcSEcCtD
Gadoversetamide—Pruritus—Gabapentin—epilepsy syndrome	0.000124	0.000125	CcSEcCtD
Gadoversetamide—Vomiting—Pregabalin—epilepsy syndrome	0.000122	0.000122	CcSEcCtD
Gadoversetamide—Feeling abnormal—Topiramate—epilepsy syndrome	0.000122	0.000122	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000121	0.000121	CcSEcCtD
Gadoversetamide—Rash—Pregabalin—epilepsy syndrome	0.000121	0.000121	CcSEcCtD
Gadoversetamide—Dermatitis—Pregabalin—epilepsy syndrome	0.000121	0.000121	CcSEcCtD
Gadoversetamide—Diarrhoea—Gabapentin—epilepsy syndrome	0.00012	0.000121	CcSEcCtD
Gadoversetamide—Headache—Pregabalin—epilepsy syndrome	0.00012	0.00012	CcSEcCtD
Gadoversetamide—Urticaria—Topiramate—epilepsy syndrome	0.000117	0.000118	CcSEcCtD
Gadoversetamide—Abdominal pain—Topiramate—epilepsy syndrome	0.000117	0.000117	CcSEcCtD
Gadoversetamide—Body temperature increased—Topiramate—epilepsy syndrome	0.000117	0.000117	CcSEcCtD
Gadoversetamide—Dizziness—Gabapentin—epilepsy syndrome	0.000116	0.000117	CcSEcCtD
Gadoversetamide—Nausea—Pregabalin—epilepsy syndrome	0.000114	0.000114	CcSEcCtD
Gadoversetamide—Vomiting—Gabapentin—epilepsy syndrome	0.000112	0.000112	CcSEcCtD
Gadoversetamide—Rash—Gabapentin—epilepsy syndrome	0.000111	0.000111	CcSEcCtD
Gadoversetamide—Dermatitis—Gabapentin—epilepsy syndrome	0.000111	0.000111	CcSEcCtD
Gadoversetamide—Headache—Gabapentin—epilepsy syndrome	0.00011	0.00011	CcSEcCtD
Gadoversetamide—Hypersensitivity—Topiramate—epilepsy syndrome	0.000109	0.000109	CcSEcCtD
Gadoversetamide—Asthenia—Topiramate—epilepsy syndrome	0.000106	0.000106	CcSEcCtD
Gadoversetamide—Pruritus—Topiramate—epilepsy syndrome	0.000104	0.000105	CcSEcCtD
Gadoversetamide—Nausea—Gabapentin—epilepsy syndrome	0.000104	0.000105	CcSEcCtD
Gadoversetamide—Diarrhoea—Topiramate—epilepsy syndrome	0.000101	0.000102	CcSEcCtD
Gadoversetamide—Dizziness—Topiramate—epilepsy syndrome	9.77e-05	9.81e-05	CcSEcCtD
Gadoversetamide—Vomiting—Topiramate—epilepsy syndrome	9.39e-05	9.43e-05	CcSEcCtD
Gadoversetamide—Rash—Topiramate—epilepsy syndrome	9.31e-05	9.36e-05	CcSEcCtD
Gadoversetamide—Dermatitis—Topiramate—epilepsy syndrome	9.3e-05	9.35e-05	CcSEcCtD
Gadoversetamide—Headache—Topiramate—epilepsy syndrome	9.25e-05	9.29e-05	CcSEcCtD
Gadoversetamide—Nausea—Topiramate—epilepsy syndrome	8.77e-05	8.81e-05	CcSEcCtD
